Trademark: 88278778
Status Date
Tuesday, April 7, 2020
Registration Number
6026619
Registration Date
Tuesday, April 7, 2020
Filing Date
Monday, January 28, 2019
Published for Opposition
Tuesday, January 21, 2020
40 Manufacture of pharmaceutical products, medicinal products, medicaments from pharmaceutical compositions for third parties; all the aforementioned only in relation to drug delivery agents or systems based on an engineered protein capsule and/or pharmaceutical products or preparations for use with a drug delivery agent or system based on an engineered protein capsule; none of the aforementioned for use in connection with the treatment or prevention of hepatitis
5 Diagnostic preparations for medical purposes; vaccines; pharmaceutical preparations, namely, adjuvants, carriers for active ingredients and drug delivery systems based on an engineered protein capsule for medical use in humans or animals, implants comprising active ingredients for the prevention or treatment of neurological, neurodegenerative, psychiatric, immune system related, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, urological, gynecological, reproductive, oncological, ophthalmic, respiratory, gastrointestinal, hormonal, dermatological, lymphatic, inflammatory, infectious, hematological, renal, genetic, bacterial and viral diseases, sexual dysfunction and pain as well as for gene therapy, vaccination or immunostimmulation; all the aforementioned goods only being either drug delivery agents based on an engineered protein capsule or pharmaceutical products or preparations for use with a drug delivery agent or system based on an engineered protein capsule; none of the aforementioned goods for use in connection with the treatment or prevention of hepatitis
1 Chemical, biological, biochemical and biotechnological products and preparations for industrial and scientific purposes, namely, small molecules, biologics, nucleic acids, proteins, lipids, polysaccharides, enzymes, antibodies, cells, microorganisms, protein-based capsids or particles as well as fragments, fractions and derivatives thereof
42 Scientific research and development for third parties, in particular in the fields of medicine, pharmacy, diagnostics, chemistry, biology, biochemistry and biotechnology; scientific research and development with regard to the manufacture of pharmaceutical preparations, carriers for active ingredients and drug delivery systems for use in humans or animals, for third parties; development of pharmaceutical preparations, namely, medical products for the prevention and treatment of neurological, neurodegenerative, psychiatric, immune system related, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, urological, gynecological, reproductive, oncological, ophthalmic, respiratory, gastrointestinal, hormonal, dermatological, lymphatic, inflammatory, infectious, hematological, renal, genetic, bacterial and viral diseases, sexual dysfunction and pain as well as for gene therapy, vaccination or immunostimmulation, for third parties
Apr 26, 2022
Applicant/Correspondence Changes (Non-Responsive) Entered
Apr 26, 2022
Teas Change Of Correspondence Received
Apr 26, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Apr 26, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Apr 26, 2022
Teas Change Of Owner Address Received
Apr 7, 2020
Registered-Principal Register
Jan 21, 2020
Official Gazette Publication Confirmation E-Mailed
Jan 21, 2020
Published For Opposition
Jan 1, 2020
Notification Of Notice Of Publication E-Mailed
Dec 17, 2019
Approved For Pub - Principal Register
Dec 17, 2019
Examiner's Amendment Entered
Dec 16, 2019
Notification Of Examiners Amendment E-Mailed
Dec 16, 2019
Examiners Amendment E-Mailed
Dec 16, 2019
Examiners Amendment -Written
Nov 22, 2019
Notification Of Non-Final Action E-Mailed
Nov 22, 2019
Non-Final Action E-Mailed
Nov 22, 2019
Non-Final Action Written
Nov 1, 2019
Examiner's Amendment Entered
Nov 1, 2019
Notification Of Examiners Amendment E-Mailed
Nov 1, 2019
Examiners Amendment E-Mailed
Nov 1, 2019
Examiners Amendment -Written
Oct 15, 2019
Teas/Email Correspondence Entered
Oct 15, 2019
Correspondence Received In Law Office
Oct 15, 2019
Applicant/Correspondence Changes (Non-Responsive) Entered
Oct 9, 2019
Teas Response To Suspension Inquiry Received
Oct 9, 2019
Teas Withdrawal Of Attorney Received-Firm Retains
Jul 17, 2019
Notification Of Letter Of Suspension E-Mailed
Jul 17, 2019
Letter Of Suspension E-Mailed
Jul 17, 2019
Suspension Letter Written
Jun 27, 2019
Data Modification Completed
Jun 27, 2019
Teas/Email Correspondence Entered
May 9, 2019
Correspondence Received In Law Office
Jun 12, 2019
Teas Change Of Correspondence Received
Jun 10, 2019
Notification Of Letter Of Suspension E-Mailed
Jun 10, 2019
Letter Of Suspension E-Mailed
Jun 10, 2019
Suspension Letter Written
May 21, 2019
Teas/Email Correspondence Entered
May 21, 2019
Correspondence Received In Law Office
May 17, 2019
Assigned To Lie
May 10, 2019
Teas Response To Office Action Received
May 9, 2019
Teas Response To Office Action Received
Apr 12, 2019
Notification Of Non-Final Action E-Mailed
Apr 12, 2019
Non-Final Action E-Mailed
Apr 12, 2019
Non-Final Action Written
Apr 9, 2019
Assigned To Examiner
Feb 25, 2019
Preliminary/Voluntary Amendment - Entered
Feb 21, 2019
Assigned To Lie
Feb 20, 2019
New Application Office Supplied Data Entered In Tram
Feb 14, 2019
Teas Voluntary Amendment Received
Jan 31, 2019
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
